StockNews.AI
EW
StockNews.AI
21 days

Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase

1. Edwards Lifesciences announced a $500 million accelerated share repurchase. 2. This increases total repurchases to over $800 million in 2025.

Shares Buyback
+3.12%Current Return
VS
-0.26%S&P 500
$78.9308/19 04:46 PM EDTEvent Start
$81.3908/20 10:54 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

Share repurchase indicates confidence in company's financial health. Historical data shows similar repurchases often lead to stock price increases.

How important is it?

The $500 million ASR represents a significant commitment, likely boosting investor confidence and affecting share price.

Why Short Term?

ASR announcements typically influence prices quickly. Past ASRs have resulted in immediate positive market reactions.

Related Companies

MSCIABTMDT
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced that it has executed an accelerated share repurchase agreement ("ASR") to repurchase $500 million of Edwards' common stock. With this transaction, Edwards has repurchased more than $800 million of shares in 2025. Under the terms of this ASR, Edwards will receive an initial delivery of approximately 5 million shares and the remainder at the maturity of the ASR. The final number of shares to be repurchased will be ba.

Related News